SCHEMBL27419635

SCHEMBL27419635

c1ccc(-c2ccc(N3CCCCC3)nn2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.59
LMNA P02545 2/20 0.59
THRB P10828 1/20 0.59
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
TSHR P16473 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
KDM4E B2RXH2 1/20 0.58
MEN1 O00255 1/20 0.58
ALDH1A1 P00352 1/20 0.58
MAPT P10636 1/20 0.58
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
KMT2A Q03164 1/20 0.58
RELA Q04206 1/20 0.58
HPGD P15428 1/20 0.57
RECQL P46063 1/20 0.57
CHRNA7 P36544 3/20 0.56
HTR3A P46098 1/20 0.56
CHRNB4 P30926 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6351786 0.84 CHRNA7 (0.59) TP53LMNATHRBNPC1RAB9A
SCHEMBL6359471 0.84 CHRNA7 (0.56) TP53LMNATHRBNPC1RAB9A
SCHEMBL1752881 0.84 MAPT (0.61) TP53LMNANPC1RAB9ATSHR
SCHEMBL12540868 0.84 NPC1 (0.57) TP53LMNATHRBNPC1RAB9A
SCHEMBL1752837 0.83 CNR2 (0.64) TP53NPC1RAB9ATSHRSMN1; SMN2
SCHEMBL2760767 0.83 CHRNA7 (0.61) TP53NPC1RAB9ATSHRSMN1; SMN2
SCHEMBL1752797 0.83 CHRNA7 (0.66) TP53NPC1RAB9ATSHRSMN1; SMN2
SCHEMBL29061006 0.81 NPC1 (0.49) TP53LMNATHRBNPC1RAB9A
SCHEMBL1752802 0.80 MAPT (0.58) TP53LMNANPC1RAB9ATSHR
SCHEMBL1752870 0.80 TSHR (0.57) TP53LMNANPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208923-A1 SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION JNANA THERAPEUTICS INC. 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208923-A1 SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION SLC18A2, SLC6A19, SLC1A1 TP53 2691/4885LMNA 3886/4885THRB 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.